HRP20030220B1 - Bicyclic heteroaromatic compounds - Google Patents

Bicyclic heteroaromatic compounds

Info

Publication number
HRP20030220B1
HRP20030220B1 HR20030220A HRP20030220A HRP20030220B1 HR P20030220 B1 HRP20030220 B1 HR P20030220B1 HR 20030220 A HR20030220 A HR 20030220A HR P20030220 A HRP20030220 A HR P20030220A HR P20030220 B1 HRP20030220 B1 HR P20030220B1
Authority
HR
Croatia
Prior art keywords
bicyclic heteroaromatic
heteroaromatic compounds
thieno
methylthio
carboxamide
Prior art date
Application number
HR20030220A
Other languages
English (en)
Croatian (hr)
Inventor
Marius Timmers Cornelis
Frederik Johan Karstens Willem
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20030220A2 publication Critical patent/HRP20030220A2/hr
Publication of HRP20030220B1 publication Critical patent/HRP20030220B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20030220A 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds HRP20030220B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (2)

Publication Number Publication Date
HRP20030220A2 HRP20030220A2 (en) 2003-06-30
HRP20030220B1 true HRP20030220B1 (en) 2011-10-31

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030220A HRP20030220B1 (en) 2000-09-22 2003-03-21 Bicyclic heteroaromatic compounds

Country Status (32)

Country Link
US (2) US7229990B2 (hu)
EP (2) EP1886999A3 (hu)
JP (1) JP4977940B2 (hu)
KR (1) KR100860040B1 (hu)
CN (1) CN1247594C (hu)
AR (1) AR030784A1 (hu)
AT (1) ATE384726T1 (hu)
AU (2) AU2002213929B2 (hu)
BR (1) BR0113987A (hu)
CA (1) CA2422054C (hu)
CY (1) CY1107308T1 (hu)
CZ (1) CZ297136B6 (hu)
DE (1) DE60132607T2 (hu)
DK (1) DK1322651T3 (hu)
EC (1) ECSP034523A (hu)
ES (1) ES2299524T3 (hu)
HK (1) HK1054942A1 (hu)
HR (1) HRP20030220B1 (hu)
HU (1) HU229422B1 (hu)
IL (2) IL154624A0 (hu)
IS (1) IS2531B (hu)
MX (1) MXPA03002478A (hu)
NO (1) NO328683B1 (hu)
NZ (1) NZ524444A (hu)
PE (1) PE20020537A1 (hu)
PL (1) PL207755B1 (hu)
PT (1) PT1322651E (hu)
RU (1) RU2271360C2 (hu)
SK (1) SK287554B6 (hu)
TW (1) TWI290143B (hu)
WO (1) WO2002024703A1 (hu)
ZA (1) ZA200301588B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886999A3 (en) * 2000-09-22 2008-03-12 N.V. Organon Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
MX2007014517A (es) * 2005-05-17 2008-02-11 Schering Corp Heterociclos como agonistas del receptor de acido nicotinico para el tratamiento de dislipidemia.
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AU2007254165A1 (en) * 2006-05-17 2007-11-29 Forschungsverbund Berlin E.V. Pyrimidine low molecular weight ligands for modulating hormone receptors
CA2719868A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag Pyrimidinyl pyridone inhibitors of jnk.
WO2010047674A1 (en) 2008-10-20 2010-04-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
JP5965387B2 (ja) 2010-04-08 2016-08-03 アメリカ合衆国 Tsh受容体用のインバースアゴニストおよびニュートラルアンタゴニスト
BR112014003981A2 (pt) 2011-08-23 2017-03-07 Endo Pharmaceuticals Inc compostos de pirimido-piridazinona e seu uso
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (en) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
WO2000061586A1 (en) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Bicyclic heteroaromatic compounds useful as lh agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044041A1 (en) * 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
EP1886999A3 (en) * 2000-09-22 2008-03-12 N.V. Organon Bicyclic heteroaromatic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995034563A1 (en) * 1994-06-16 1995-12-21 Pfizer Inc. Pyrazolo and pyrrolopyridines
WO2000061586A1 (en) * 1999-04-08 2000-10-19 Akzo Nobel N.V. Bicyclic heteroaromatic compounds useful as lh agonists

Also Published As

Publication number Publication date
EP1322651A1 (en) 2003-07-02
PT1322651E (pt) 2008-02-28
IL154624A0 (en) 2003-09-17
CN1462273A (zh) 2003-12-17
HU229422B1 (hu) 2013-12-30
HUP0302648A2 (hu) 2003-11-28
CZ297136B6 (cs) 2006-09-13
SK287554B6 (sk) 2011-01-04
US7618963B2 (en) 2009-11-17
IS6732A (is) 2003-02-28
PL207755B1 (pl) 2011-01-31
JP2004509896A (ja) 2004-04-02
MXPA03002478A (es) 2004-05-05
US7229990B2 (en) 2007-06-12
AU2002213929B2 (en) 2006-04-13
CZ2003828A3 (cs) 2003-08-13
EP1322651B1 (en) 2008-01-23
ATE384726T1 (de) 2008-02-15
HRP20030220A2 (en) 2003-06-30
DE60132607D1 (de) 2008-03-13
HK1054942A1 (en) 2003-12-19
EP1886999A2 (en) 2008-02-13
EP1886999A3 (en) 2008-03-12
BR0113987A (pt) 2003-08-12
IS2531B (is) 2009-07-15
HUP0302648A3 (en) 2004-11-29
NO328683B1 (no) 2010-04-26
CY1107308T1 (el) 2012-11-21
NZ524444A (en) 2004-03-26
DE60132607T2 (de) 2009-01-29
RU2271360C2 (ru) 2006-03-10
IL154624A (en) 2009-09-01
ZA200301588B (en) 2004-06-22
CA2422054A1 (en) 2002-03-28
DK1322651T3 (da) 2008-06-02
EP1886999A8 (en) 2010-08-04
ES2299524T3 (es) 2008-06-01
AR030784A1 (es) 2003-09-03
US20070197527A1 (en) 2007-08-23
PL360675A1 (en) 2004-09-20
WO2002024703A1 (en) 2002-03-28
NO20031314L (no) 2003-03-21
PE20020537A1 (es) 2002-06-20
JP4977940B2 (ja) 2012-07-18
CN1247594C (zh) 2006-03-29
NO20031314D0 (no) 2003-03-21
CA2422054C (en) 2011-01-11
KR20030040483A (ko) 2003-05-22
ECSP034523A (es) 2003-04-25
SK3312003A3 (en) 2003-08-05
KR100860040B1 (ko) 2008-09-25
TWI290143B (en) 2007-11-21
US20030225113A1 (en) 2003-12-04
AU1392902A (en) 2002-04-02

Similar Documents

Publication Publication Date Title
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
PT1289992E (pt) Nova forma cristalina de um composto de triazolo (4,5-d) pirimidina
CA2416867A1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
GB0124627D0 (en) Novel compounds
SI1379511T1 (en) DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
HRP20030220B1 (en) Bicyclic heteroaromatic compounds
MA26824A1 (fr) 5-(2-substitué-5-hétérocyclylsulfonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidine-7-ones servant d'inhibiteurs de phosphodiestérase.
ID28432A (id) Senyawa-senyawa baru
SI1379522T1 (en) DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
HRP20010117B1 (en) Novel salt form of pantoprazole
DZ3266A1 (fr) Pyrido[2,3-d]pyrimidine-2,7-diamine inhibiteurs de kinase
MXPA02011319A (es) Analogos antitumorales de ecteinascidina 743.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
ATE248822T1 (de) Partikel mit kontrollierter freisetzungsrate
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
AU5539899A (en) Novel triazolo(4,5-(d))pyrimidine compounds
TR199901017A2 (xx) B�cek ilac� terkibi.
MXPA03004498A (es) Uso de pirazolo (4,3-d)pirimidinas.
AU9259501A (en) Interphenylene 7-oxabicyclic(2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
GB2418915B (en) Fragrance compositions comprising benzo[4,5]thieno[3,2-B]pyran-2-one
AU9069201A (en) Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
PL356668A1 (en) Novel substituted pyrazolo[4,3-e

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: N.V. ORGANON, NL

B1PR Patent granted
PPPP Transfer of rights

Owner name: MSD OSS B.V., NL

PPPP Transfer of rights

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL

ODRP Renewal fee for the maintenance of a patent

Payment date: 20140826

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20150917